Beam co-founder describes base editors with reduced RNA editing

TECHNIQUES CATEGORY: Drug platforms

TECHNOLOGY: Gene therapy

Beam Therapeutics co-founder J. Keith Joung and colleagues described cytosine

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE